← Back to headlines
Guggenheim Cuts Price Target for Valneva SE
Guggenheim has lowered its price target for Valneva SE (VALN) from $13 to $11. This adjustment reflects a revised financial outlook for the European biotechnology company.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
